---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-006678"
form_type: "8-K/A"
ticker: "ETON"
cik: "0001710340"
company_name: "Eton Pharmaceuticals, Inc."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T03:50:58.550008+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Eton noncompliant with SEC reporting after Increlex acquisition; unable to provide audited financials

## Summary
- Acquisition of Increlex from Ipsen closed Dec 19, 2024; must be accounted for as business combination.
- Historical financial statements for Increlex do not exist; Eton cannot create them.
- Filed SEC waiver request for Item 9.01 financial statement requirement.
- Noncompliance renders Eton ineligible for Form S-3 and substantially curtails capital raising.
- Until waiver granted or financials filed, no new registration statements can be declared effective.

## SEC filing metadata
- accession: 0001437749-25-006678
- form_type: 8-K/A
- ticker: ETON
- cik: 0001710340
- company_name: Eton Pharmaceuticals, Inc.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 9.01, 2.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710340/000143774925006678/0001437749-25-006678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710340/000143774925006678/eton20250224_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-006678
- JSON: https://secwatch.observer/filing/0001437749-25-006678.json
- Plain text: https://secwatch.observer/filing/0001437749-25-006678.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.